Wat we weten over het Russische Spoetnik-V vaccinBY DUNCAN

  • Gepubliceerd op: 09-09-2020 - 07:52
  • Bron:
  • Delen:
  • Whatsapp
  • Facebook
  • Twitter

Wat we weten over het Russische Spoetnik-V vaccinBY DUNCAN September 8, 2020 – Russia’s “Sputnik-V” vaccine produced an antibody response in all the 76 participants in phase 1/2 trials. The so-called viral vector vaccine has now started a 40,000-strong phase 3 trial. Viral vector vaccines employ a harmless version of another virus that lacks the gene responsible for replication in a human host cell. Vectors carry the genetic material to trigger the required immune response. Sputnik-V employs a “spike glycoprotein” gene which the virus uses to enter a human cell. Sputnik-V uses two adenovirus vectors to carry the gene, AD26 or AD5. Sc …
Lees Verder